| Followers | 73 |
| Posts | 3034 |
| Boards Moderated | 0 |
| Alias Born | 06/01/2012 |
Friday, November 01, 2013 11:16:25 PM
I'm trying to figure out why post #903 was deleted. it was a chart of ANIP that said RSI of 35 and OVERSOLD.
why or to whom was that post a threat?
I understand it was in reply to a post or private message I made to the poster conix. I just don't get it.
homedlice10 can you shed some light on this? with you being a mod you will know if you or the other mod deleted the post or if it was done by an admin
thanks in advance
why or to whom was that post a threat?
I understand it was in reply to a post or private message I made to the poster conix. I just don't get it.
homedlice10 can you shed some light on this? with you being a mod you will know if you or the other mod deleted the post or if it was done by an admin
thanks in advance
Recent ANIP News
- ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/27/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 08:13:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:16:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:15:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:15:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 03:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 12:27:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 10:34:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 08:51:01 PM
- ANI Pharmaceuticals (ANIP) shares jump after earnings beat and higher outlook • IH Market News • 05/08/2026 01:45:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 10:58:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 10:56:34 AM
- ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance • GlobeNewswire Inc. • 05/08/2026 10:50:00 AM
- ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET • GlobeNewswire Inc. • 04/24/2026 10:50:00 AM
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity • GlobeNewswire Inc. • 04/20/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 08:40:36 PM
- ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules • IH Market News • 04/13/2026 03:12:39 PM
- ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules • GlobeNewswire Inc. • 04/13/2026 10:50:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:14:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:13:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:12:05 PM
- ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet • GlobeNewswire Inc. • 04/08/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:21:22 PM
- ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology • GlobeNewswire Inc. • 04/07/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:48 PM
